Authors:
de Sevaux, RGL
Gregoor, PJHS
Hene, RJ
Hoitsma, AJ
Vos, P
Weimar, W
van Gelder, T
Hilbrands, LB
Citation: Rgl. De Sevaux et al., A controlled trial comparing two doses of cyclosporine in conjunction withmycophenolate mofetil and corticosteroids, J AM S NEPH, 12(8), 2001, pp. 1750-1757
Authors:
ter Meulen, CG
Gregoor, PJHS
Weimar, W
Hilbrands, LB
Citation: Cg. Ter Meulen et al., Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone, TRANSPLAN I, 14(2), 2001, pp. 99-102
Authors:
van Besouw, NM
van der Mast, BJ
de Kuiper, P
Gregoor, PJHS
Vaessen, LMB
IJzermans, JNM
van Gelder, T
Weimar, W
Citation: Nm. Van Besouw et al., T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy, TRANSPLAN P, 33(3), 2001, pp. 2239-2240
Authors:
van der Mast, BJ
van Besouw, NM
de Kuiper, P
Vaessen, LMB
Gregoor, PJHS
IJzermans, JNM
van Gelder, T
Claas, FHJ
Weimar, W
Citation: Bj. Van Der Mast et al., Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression., TRANSPLANT, 72(5), 2001, pp. 873-880
Citation: Pjhs. Gregoor et al., Mycophenolate mofetil, Cellcept (R), a new immunosuppressive drug with great potential in internal medicine, NETH J MED, 57(6), 2000, pp. 233-246
Authors:
van Besouw, NM
van der Mast, BJ
de Kuiper, P
Gregoor, PJHS
Vaessen, LMB
Ijzermans, JNM
van Gelder, T
Weimar, W
Citation: Nm. Van Besouw et al., Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced, TRANSPLANT, 70(1), 2000, pp. 136-143
Authors:
Gregoor, PJHS
van Gelder, T
van Besouw, NM
van der Mast, BJ
Ijzermans, JNM
Weimar, W
Citation: Pjhs. Gregoor et al., Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction, TRANSPLANT, 70(1), 2000, pp. 143-148
Authors:
Gregoor, PJHS
van Gelder, T
Hesse, CJ
van der Mast, BJ
van Besouw, NM
Weimar, W
Citation: Pjhs. Gregoor et al., Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study, NEPH DIAL T, 14(3), 1999, pp. 706-708
Authors:
van Besouw, NM
van der Mast, BJ
Gregoor, PJHS
Hesse, CJ
IJzermans, JNM
van Gelder, T
Weimar, W
Citation: Nm. Van Besouw et al., Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels, NEPH DIAL T, 14(11), 1999, pp. 2710-2713
Authors:
Gregoor, PJHS
van Gelder, T
van der Ende, ME
Ijzermans, JNM
Weimar, W
Citation: Pjhs. Gregoor et al., Cyclosporine and triple-drug treatment with human immunodeficiency virus protease inhibitors, TRANSPLANT, 68(8), 1999, pp. 1210-1210
Authors:
Gregoor, PJHS
de Sevaux, RGL
Hene, RJ
Hesse, CJ
Hilbrands, LB
Vos, P
van Gelder, T
Hoitsma, AJ
Weimar, W
Citation: Pjhs. Gregoor et al., Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients, TRANSPLANT, 68(10), 1999, pp. 1603-1606